Arrowhead Research ARWR Business Segments — Research And Development Expense, Excluding Noncash Expense

Similar metrics at other companies

MDGLReportable Segment — Research and Development External Expense

$94.09M+2,166%

IQVResearch And Development Solutions — Cost Of Services Excluding Depreciation Depletion And Amortization

$971M+5.4%

CGNXResearch, Development and Engineering Expenses — Other Expenses

$10.33M+4.0%

NRGOperating Segments — Research And Development Expense

$16.75M-24.7%

TRA

TRAXVPreclinical And Other Unallocated Costs — Research And Development Expense Reversal Excluding Acquired In Process Cost

——

AAX

AAXNOperating Segments — Research And Development Expense

——

Questions, answered.

What is Arrowhead Research's business segments — research and development expense, excluding noncash expense?

Arrowhead Research (ARWR) reported business segments — research and development expense, excluding noncash expense of $159.09M in Q1 2026.

How has Arrowhead Research's business segments — research and development expense, excluding noncash expense changed year-over-year?

Arrowhead Research's business segments — research and development expense, excluding noncash expense increased by 33.0% year-over-year, from $119.64M to $159.09M.

What does business segments — research and development expense, excluding noncash expense mean?

Total cash expenditures for research and development activities, excluding non-cash items.

How do you interpret business segments — research and development expense, excluding noncash expense?

Higher spending indicates aggressive investment in R&D, while lower spending may improve short-term cash flow but could impact long-term pipeline viability.

How does business segments — research and development expense, excluding noncash expense compare across companies?

Similar to 'Cash R&D Burn' or 'Adjusted R&D Expense' used by biotech investors.